The Antileishmanial Activity of Lepidines

Authors:
  • KKKenneth E. Kinnamon
    Kenneth E. Kinnamon
  • ESEdgar A. Steck
    Edgar A. Steck
  • PLPeter S. Loizeaux
    Peter S. Loizeaux
  • WHWilliam L. Hanson
    William L. Hanson
  • WCWillie L. Chapman
    Willie L. Chapman
  • VWVirginia B. Waits
    Virginia B. Waits

Abstract
A series of lepidines (6-methoxy-4-methyl-8-aminoquinoline derivatives) was studied in a hamster-Leishmania donovani model. Members of this class were found to have activity many-fold that of the standard, meglumine antimoniate (Glucantime®). One of them, 8-(6-diethylamino-hexylamino)-6-methoxy-4-methylquinoline, designated WR 6026, when given orally was over 700 times as effective as the standard antimonial drug.

This publication has 2 references indexed in Scilit: